Introduction
The management of aneurysmal subarachnoid haemorrhage has changed dramatically in the last few decades. The International Cooperative Study on the Timing of Aneurysm Surgery was the first large-scale, prospective, observational study to look at the issue of timing, and they also addressed factors that influenced outcome at 6 months stratified by Glasgow Outcome Scale (GOS). With 3521 patients recruited out of 8879 patients with SAH between 1980 and 1983, 1,2 75% of those admitted within 3 days were in good condition, with a 58% good recovery at 6 months, and 25% death rate. Initial bleed, vasospasm and rebleeding were the major causes of death and disability. A number of key prognostic factors identified included admission Glasgow coma scale (GCS) (75% who were alert on admission had good recovery, compared to 11% who were comatose) and age (only 26% of those between 70 and 87 years had a good outcome). The results also showed that at 6 months, 69% who had surgery had good outcome, with alert patients preoperatively had a favourable prognosis if operated between days 0-3 or after day 10. Subgroup analysis then showed that 71% versus 62% of patients operated on between days 0-3 versus days >10 had good recovery (p<0.01). 3 This study confirmed that older, poor-grade patients with pre-existing medical conditions have a bleak prognosis. It also prompted an international change on the timing to early surgery for good grade patients.
The International Subarachnoid Aneurysm Trial (ISAT) [4] [5] [6] was the first large scale randomized trial of endovascular coiling vs. microsurgical clipping of ruptured aneurysms. 2143 patients from the initial 9559 patients screened were randomized, and a statistically significant outcome difference (using mRS) of 7% was found at one year in favour of coiled patients. Of the enrolled patients, 88% were good grades (WFNS class I or II), 95% were anterior circulation aneurysm, and 90% were smaller than 10mm. The trial result has since been generalized to most patients with aSAH in many parts of the world, with over 90% of cerebral aneurysms managed by endovascular coiling in many UK neurosurgical centres. 7, 8 With technological advances over the last two decades, changing practice in the management of aSAH patients, increasing proportion of patients coiled, and improvements in both microsurgical and endovascular techniques there is a need for to reassess the factors determining patients' outcome in a contemporary series.
The Simvastatin in aneurysmal subarachnoid haemorrhage (STASH) trial was an international, multicentre, parallel group, double-blinded, randomized phase 3 trial. It was designed to determine whether simvastatin 40mg could improve the long-term outcome of patients with aSAH. 803 patients were recruited from 35 neurosurgical units (23 in the UK and 12 non-UK sites)
between January 2007 and February 2013. Details of the study are described in a previous paper.
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The aim of the present study was to analyse the STASH cohort to identify risk factors for poor outcome and to compare the outcome between those managed by neurosurgical clipping and endovascular coiling. focusing on patients with good grade aSAH (in line with the ISAT cohort).
Materials and Methods

Trial design and participants
Baseline demographic and outcome data were available on the 803 patients recruited from the STASH trial for post hoc analysis. 
Outcomes
The primary outcome was the distribution of modified Rankin Scale (mRS) at 6 months by means of a standardized questionnaire. Secondary outcomes were death at 6 months, delayed ischaemic deficit, delayed ischaemic deficit requiring rescue therapy, admission to an intensive care unit, incidence of sepsis, discharge destination, quality of life as measured by the SF-36 (short form health survey questionnaire) at 6months. These secondary outcomes were preselected to provide supportive evidence related to the primary outcome. We defined delayed ischaemic deficit as a deterioration of two or more points on the Glasgow Coma Scale or the development of new neurological deficit that could not be attributed to any other cause including sepsis. We defined sepsis when clinical symptoms (eg raised temperature, raised white cell count, tachycardia, or raised respiratory rate) had microbiological confirmation. Use of hypervolaemic and inotropic rescue treatment was that adopted by every centre and did not follow any prescribed definition.
Statistical Analysis
Conventional dichotomy of favourable mRS (0-2) versus unfavourable mRS (3) (4) (5) (6) was used for outcome analysis.
Comparison 
Subgroup Analysis
In order to simulate the baseline demographics of the ISAT cohort using this dataset, further analysis focused on patients with good grade aSAH (WFNS grade I and II) was performed to compare the treatment outcome between those managed by neurosurgical clipping and endovascular coiling. Baseline demographics, primary and secondary outcome, and 6 months quality of life score were compared using chi-square test, two-sample t-test as appropriate.
Result
80% of patients managed by endovascular coiling were good grade on admission (WFNS I, II) compared to 60% in the neurosurgical arm, figure 1.
More patients in the clipping arm had intraparenchymal haemorrhage (23%) compared 9% in the coiled group. The remaining baseline characteristics were well matched (Table 1) .
Good outcome at discharge was observed in 67% of patients post coiling compared to 47% in the post-clipping group (p=0.0001) ( Figure 1B ).
Comparison of outcome at 6 months is shown in Table 2 . Apart from the location of aneurysms, all other factors (age, WFNS grade, Fisher grade, treatment used, ictus to treatment time, delayed cerebral ischaemia, sepsis)
show statistically significant association with poor outcome. 32% of older patients (age over 50 years) (120/400) were associated with poor outcome compared to 25% (91/382) of younger patients (age 18-50 years) (p=0.028).
53% of patients with poor grade SAH had poor outcome at 6 months, compared to 19% of patients with good grade SAH (p<0.0001). 34% of patients who underwent clipping had poor outcome compared to 25% of patients who underwent coiling (p=0.017).
To address the issue of confounding factors, logistic regression analysis was performed ( Table 3) . The risk factors which were associated with poor outcome were poor WFNS grade on admission, Fisher grade on initial CT scan and the development of delayed cerebral ischaemia. Treatment modality was not shown to be associated with poor outcome at 6 months (p=0.839).
Propensity Matched analysis
Using the optimal propensity score matching procedure a subgroup of 498 patients (249 coiled and 249 clipped) were selected. Age, sex, admission WFNS grade, Fisher score, and proportion of patients ventilated were not significantly different between the matched groups (Table 4) . However, the distribution of aneurysms could not be fully matched due to the larger number of middle cerebral aneurysms that were clipped. Nonetheless, there was no significant difference in the incidence of confirmed DIND or sepsis between the matched groups. Moreover, 6 month mRS scores and overall favourable neurological outcome was not significantly different between coiling and clipping ( Table 4) .
Subgroup analysis
560 patients were good grade (WFNS I & II) on admission. Of these, 408
(73%) had endovascular coiling and 152 (27%) had neurosurgical clipping.
Baseline clinical and demographic characteristics were shown in Table 5 . The proportion of WFNS grade I and II, Fisher grade for SAH blood load on CT scan, and imaging modality was well matched in both groups. The distribution of aneurysms selected for coiling and clipping varied. The anterior communicating artery aneurysms were most commonly coiled (36%) compared with the middle cerebral artery aneurysms most commonly treated surgically (36%). Time from ictus to treatment of aneurysms was similar for both groups.
Immediate procedural related problems or complications (intraoperative rupture, uncontrolled brain swelling, major vessel occlusion, thromboembolic event) were low in both groups, and no statistically significant differences were detected.
The rate of confirmed delayed cerebral ischaemia was lower in patients who had endovascular coiling (11%) compared to patients who had neurosurgical clipping (21%), (p=0.001). There was also a lower risk of developing sepsis for patients post coiling (13%) compared to clipping (23%), (p=0.001). A lower proportion of patients post coiling were admitted to HDU/ITU (41% vs 53%, p=0.012), needed extended hypervolaemic therapy (16% vs 30%, p=0.001), or required inotropic support (17% vs 30%, p=0.001). The rate of patients needing other rescue therapy for delayed cerebral ischaemia (angioplasty, intra-arterial papaverine or nimodipine) was similar between the two groups, (Table 6 ).
The mean length of hospital stay for coiling group of patients was 16.3 days (range 5-119 days), compared to patients who underwent clipping 18.9 days (range 4-120 days). 74% of patients managed by endovascular coiling was discharged home, compared to 66% of surgical patients, but this difference is not statistically significant (p=0.110).
At discharge, favourable outcome (mRS 0-2) was observed in 76% of post coiled patients, compared to 66% of patients post clipping (p=0.06, Table 6 , Figure 2 ). This rate subsequently improved. At 6 months 82% of patients post coiling, and 78% of patients post clipping were classed as good outcome (p=0.181, Table 6 , Figure 2 ). At 6 months, 3% of post coiling patients, and 5% of post clipping patients had died.
SF-36 at 6 months was available for 87% of patients in both treatment arms (356/408 for coiled patients, and 132/152 for clipped patients). The mean physical score, mental score and overall scores were lower in the coiling arm.
The differences noted were statistically significant, (Table 6 ).
Discussion
Initial analysis showed that older age, poor WFNS grade, high Fisher grade on initial CT head scan, treatment used (clipping), ictus to treatment time, development of delayed cerebral ischaemia and sepsis were associated with poor outcome at 6 months post aneurysmal SAH in this post-hoc study using 15 However, more recent studies showed that over 75 years as the critical age for poor outcome, 16, 17 and there are now increasing evidence of subgroups of very elderly patients being treated aggressively with good long term outcome. 18, 19 Previous studies 1, 2, 20 showed that the timing of surgery was associated with better outcome and prompted an international change on the timing to early surgery for good grade patients. The results showed that at 6 months, 69% who had surgery had good outcome, with alert patients preoperatively had a favourable prognosis if operated between days 0-3 or after day 10. Subgroup analysis from the North American cohort then showed that 71% versus 62% of patients operated on between days 0-3 versus days >10 had good recovery (p<0.01). 3 Nowadays, combined with the options of endovascular treatment, most patients (693/749, 93%) in our study had aneurysms secured early on (within 96 hours post ictus), a very different practice to the era during The
International Cooperative Study on the Timing of Aneurysm Surgery.
Inherently, there are many confounding factors that determine the timing of surgery or coiling (>96hours) for the 7% of patients in this study, i.e. those who undergo delayed treatment are generally limited by other medical factors.
Therefore it was not surprising that the timing of treatment was shown to be statistically significant predictor for poor outcome initially, with the effect lost after correction for confounding factors.
Contrary to the ISAT 4-6 study from 2002, which suggested endovascular coiling was preferable to neurosurgical clipping, this post hoc analysis of a contemporary series of patients from the STASH trial data showed no statistically significant differences between clipping and coiling at 6 months, using both propensity matched analysis and subgroup analysis of good grade patients only to simulate the ISAT cohort. Furthermore subgroup analysis showed the outcome differences noted at discharge were lost in patients with good grade aSAH managed by either treatment modality.
In the ISAT study, the ictus to treatment time was different between the two treatment modalities (mean 3.1 days for coiling, 3.7 days for clipping) and hence more patients suffered aneurysmal rebleed prior to treatment. 6, 21 In this study, time to treatment was comparable in both groups. This, coupled with modern day technology incorporating better microscopic visualization, the use of intraoperative indocyanine green (ICG) and neurosurgical clipping now performed by expert neurovascular neurosurgeon, may account for the improvement in outcome observed.
In comparison to the ISAT 4-6 and BRAT 22,23 study (Table 7) , the proportion of patients with good outcome has increased for both treatment modalities.
ISAT [4] [5] [6] reported 76% of patients post coiling, and 69% post clipping had good outcome at 1 year, compared to 81% and 78% respectively in our cohort at 6 months. Such improvement is promising, considering that when ISAT was performed, only a select group of aneurysms were included (88% were good grades (WFNS class I or II), 95% were anterior circulation aneurysm, and 90% were smaller than 10mm). Likewise the BRAT 22,23 study demonstrated a similar outcome; but with only 49% of good grade patients and with a greater proportion of posterior circulation aneurysms, they could still achieve a very comparable outcome to the ISAT study (Table 7 ). In the current era, when interventional neuroradiologists are treating the more complex and challenging aneurysms, to retain the same results is very reassuring. The more remarkable finding is that the results for neurosurgical clipping have improved even further, aided by the advent of technology, we are now in an era where good outcome could be comparable to endovascular treatment.
Our subgroup analysis showed that patients who underwent neurosurgical clipping had a higher risk of developing delayed cerebral ischaemia, although this finding was not supported by the propensity score analysis conducted.
Nevertheless, a recent meta-analysis showed that delayed cerebral ischemia was more common after clipping (OR 1.43; 95% CI 1.07-1.91), but ischemic infarct, shunt-dependent hydrocephalus, and procedural complications did not differ significantly between coiling and clipping. 24 Provided that patients are adequately managed, the development of delayed cerebral ischaemia in patients who had clipping did not translate into longer-term poor outcome.
Despite the use of nimodipine, which has been shown to reduce the risk of delayed cerebral ischaemia, about 25% of patients still developed it post aSAH. 25, 26 The overall level of delayed cerebral ischaemia (16%) in our cohort is lower than previously reported, and this could be attributed to more aSAH patients being treated by coil embolisation (DIND rate 21% in patients post clipping, and 11% post coiling).
The propensity-score matching analysis demonstrates that patients of similar age, sex, and severity of presenting haemorrhage (based on WFNS grade and Fisher score) have a comparable risk of developing delayed ischaemic deficits irrespective of the modality chosen to secure their aneurysm.
Similarly, neurological outcome at six months amongst the matched groups was not dependent on whether the patient was clipped or coiled. These findings do not imply that clipping and coiling are equivalent or interchangeable for all aneurysms. The inference should be that current selection criteria in determining which patients are best clipped or coiled result in equally good outcomes for both groups and there remains a clear role for both modalities. Despite the many advantages of propensity score matching analysis, one of the limitation is that it only accounts for observed covariates, and hidden bias could remain or be exaggerated after matching. 27 Therefore propensity-score matching is still not a substitute for randomization.
Good grade patients who were coiled experienced a lower SF36 score in terms of physical, mental & overall wellbeing. Such differences could be related to the psychological worry related to the longer term follow up required for the surveillance of these aneurysms to ensure they remaining static.
Conversely, in our experience, most patients who underwent neurosurgical clipping could be generally reassured of complete aneurysm obliteration.
Coiling or clipping should not be perceived as competing treatment modalities for securing cerebral aneurysms. They are complementary as both treatments have different roles in the management of aSAH. In the event of aneurysms suitable for both treatment modalities, coiling was shown to have better outcome by 7% according to the ISAT study, so endovascular treatment should be the preferred treatment. However in patients with cerebral aneurysms with anatomical configuration either less optimal or unsuitable for endovascular treatment, clipping should be offered as the first treatment modality. As shown in this paper, good grade patients do not experience a significant disadvantage post clipping, therefore neurosurgeons should not perceive clipping as the last resort only after attempted coiling.
In order to ensure that we deliver the highest standard of care for our patients, we need to continue to improve and strive to minimize technical related complications. With an increasing number of cerebral aneurysms being secured by endovascular coiling, training for the next generation of neurovascular surgeons can be challenging. However, with the advent of modern technology, realistic simulation surgery is a crucial tool for training.
Several studies have shown that complex cases performed by high volume large centres achieved better outcome than low volume smaller units. [28] [29] [30] Therefore centralisation of neurovascular centres where neurosurgical clipping cases are performed in selected centres would increase the caseload, maintain surgeons' expertise and enhance training opportunities.
This is a post-hoc analysis from STASH study, which was not designed primarily to look at the outcome difference between the two treatments modality, as such is a limitation of the study. Furthermore, the rate of aneurysms recurrence and retreatment were not part of the STASH trial protocol, and therefore not available for analysis. However, several changes to the management of aSAH in the current era and important findings were borne out in this paper.
With regards to the longer term outcomes, many studies including large scale randomized controlled trials (ISAT and BRAT) showed that retreatment and rebleeding risks were higher in the endovascular group. In BRAT study, with up to 6 years follow up, overall retreatment rates were 16.4% for coiling and 4.6% for clipping (p<0.0001). 31 In the ISAT study with up to 18 years follow up, incidence of recurrent SAH was one in 641 patient-years for coiling, versus one in 2041 patient-years for clipping. 32 However, the ISAT study also confirmed the long term durability of endovascular treatment.
Conclusion
In the current era of aSAH management, apart from patients' admission status, SAH blood load and the development of DCI, treatment modality with either coiling or clipping was not associated with poor outcome difference at 6 months. In this post-hoc study of selective patients involved in the STASH trial, the effect of age and timing from ictus to intervention was lost after correction for confounding factors, a finding not unexpected as elderly patients (over 65 years) were excluded, and over 90% of patients had their aneurysms secured early on (within 96 hours post ictus).
Within the limit of a posthoc analysis, this study also showed good grade patients managed with either coiling or clipping experienced no difference in outcome at discharge or at 6 months, including physical and mental wellbeing.
Endovascular coiling and neurosurgical clipping both have a role to play in the management of subarachnoid haemorrhage.
ISAT study randomized aneurysms suitable for both coiling and clipping, while the data has since been generalized to the entire cohort of cerebral aneurysms including the wide neck, complex aneurysms. Currently, in many UK centres, over 90% of aneurysms are coiled, as the perception has been coiling is better, and every attempt should be made to coil aneurysms (even subtotally), with surgery only a last resort. We hope that our data will help to modify this viewpoint.
The key message is that in the event of any perceived difficulty with coiling, then one can comfortably offer clipping without the concern for a long-term disadvantage for clipping. The short-term advantages for coiling are still very apparent.
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